Advertisement
Singapore markets open in 3 hours 46 minutes

  • Straits Times Index

    3,144.76
    -38.85 (-1.22%)
     

  • S&P 500

    5,051.41
    -10.41 (-0.21%)
     

  • Dow

    37,798.97
    +63.86 (+0.17%)
     

  • Nasdaq

    15,865.25
    -19.77 (-0.12%)
     

  • Bitcoin USD

    63,390.57
    +27.81 (+0.04%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • FTSE 100

    7,820.36
    -145.17 (-1.82%)
     

  • Gold

    2,399.50
    +16.50 (+0.69%)
     

  • Crude Oil

    85.31
    -0.10 (-0.12%)
     

  • 10-Yr Bond

    4.6590
    +0.0310 (+0.67%)
     

  • Nikkei

    38,471.20
    -761.60 (-1.94%)
     

  • Hang Seng

    16,248.97
    -351.49 (-2.12%)
     

  • FTSE Bursa Malaysia

    1,535.00
    -7.53 (-0.49%)
     

  • Jakarta Composite Index

    7,164.81
    -7,286.88 (-50.42%)
     

  • PSE Index

    6,404.97
    -157.46 (-2.40%)
     

Global Cancer Immunotherapy Market to Generate $309.66 Billion by 2030: Allied Market Research

Allied Market Research
·5-min read

Rise in prevalence of cancer diseases, growth in geriatric population, surge in expenditure for healthcare sector, and increasing awareness among consumers for cancer immunotherapy drive the growth of the global cancer immunotherapy market. Moreover, the market across the North America region dominated in 2020, and is expected to lead the trail by the end of 2030.

Portland, OR, Aug. 05, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Cancer Immunotherapy Market generated $85.60 billion in 2020, and is estimated to generate $309.66 billion by 2030, witnessing a CAGR of 14.1% from 2020 to 2030. The report provides a detailed analysis of changing market dynamics, key segments, value chain, regional scenario, top investment pockets, and competitive landscape.

Rise in prevalence of cancer diseases, growth in geriatric population, surge in expenditure toward health related issues, and increasing awareness among consumers for cancer immunotherapy drive the growth of the global cancer immunotherapy market. However, risk of allergic reaction and limitations of the cancer immunotherapy treatment and strict government regulations hinder the market growth. On the other hand, surge in research and development in cancer immunotherapy presents new opportunities in the coming years.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/2244

ADVERTISEMENT

Covid-19 Scenario:

  • The COVID-19 pandemic has drastically affected the buying capacity of hospitals, especially small-scale hospitals and scanning centers.

  • The clinical trials of the new cancer immunotherapy drugs are kept on hold, as during this crisis individual are more susceptible to suffer from COVID-19. COVID friendly cancer treatments, however, are observed to be increased during the course of time.

  • Also, the government bodies have issued vaccination drives all across the globe along with relaxing regulations, which is expected to help the industry revive soon.

The report offers detailed segmentation of the global cancer immunotherapy market based on technology type, application, end-user, and region.

Based on technology, the monoclonal antibodies segment held the highest share in 2020, accounting for around two-thirds of the total share, and is projected to maintain its lead position throughout the forecast period. In addition to this, the segment is also estimated to witness the highest CAGR of 14.5% from 2020 to 2030. The report also covers segments including cytokines & immunomodulators and others.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/2244

Based on end user, the hospital segment contributed to the highest market share, holding nearly three-fifths of the global cancer immunotherapy market in 2020, and is expected to maintain its lead in terms of revenue throughout the forecast period. Furthermore, the segment is also expected to manifest the largest CAGR of 14.7% from 2020 to 2030. The report also studies segment including Cancer Research Centers and clinics.

Based on region, North America accounted for the highest share in 2020, contributing to more than two-fifths of the total market share, and is expected to maintain its dominance in terms of revenue by 2030. However, Asia-Pacific is expected to register the fastest CAGR of 15.5% during the forecast period.

Leading players of the global cancer immunotherapy market analyzed in the research include Amgen, Inc., Astrazeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily And Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson & Johnson (Janssen Global Services, LLC), Merck KGAA, and Novartis AG. These market players have incorporated several strategies including partnership, expansion, collaboration, joint ventures, and others to brace their stand in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Medical Tourism Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Epigenetics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Autoinjectors Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Biosensors Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Tissue Engineering Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Digital Diabetes Management Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research